Fingerprint
Dive into the research topics of 'Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma
Beth Hellerstedt, Kenneth J. Pienta, Bruce G. Redman, Peg Esper, Rodney Dunn, Judith Fardig, Karin Olson, David C. Smith
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations